Tocilizumab, a Humanized Monoclonal Antibody Against the Interleukin-6 Receptor, Inhibits High Glucose-Induced Vascular Smooth Muscle Cell Migration Through Mitogen-Activated Protein Kinase Signaling Pathways
2018 ◽
Vol 38
(11)
◽
pp. 510-516
◽
2005 ◽
Vol 178
(2)
◽
pp. 271-277
◽
2001 ◽
Vol 38
(6)
◽
pp. 909-921
◽
1998 ◽
Vol 27
(1)
◽
pp. 117-125
◽
2018 ◽
Vol 38
(Suppl_1)
◽
2006 ◽
Vol 79
(3-4)
◽
pp. 278-286
◽
2006 ◽
Vol 26
(12)
◽
pp. 2630-2637
◽